Organizational meeting of the Board of Directors of Biotie Therapies Corp.

(Thomson Reuters ONE) -


BIOTIE THERAPIES CORP.         STOCK EXCHANGE RELEASE          7 February 2011,
at 6.15  p.m.

Organizational meeting of the Board of Directors of Biotie Therapies Corp.

Board of Directors of Biotie Therapies Corp. ("Biotie" or the "Company") held
its organizational meeting on 7 February 2011.

Peter Fellner continues as the Chairman of the Board of Directors. The Board
elected Bradley J. Bolzon as Deputy Chairman of the Board. The Board resolved
that the Company shall continue to have two committees, Audit Committee as well
as Nomination and Remuneration Committee. Members of the Audit Committee are
Bernd Kastler (Chairman), Merja Karhapää, Piet Serrure and Andrew Schwab.
Members of the Nomination and Remuneration Committee are Peter Fellner
(Chairman), Bradley J. Bolzon, William Burns and James Shannon The term of
office of the Board expires at the end of the Annual General Meeting following
their election.

In Turku, 7 February 2011

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi(at)biotie.com
www.biotie.com


Distribution:
NASDAQ OMX Helsinki Ltd
Main Media









This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Biotie Therapies Oyj via Thomson Reuters ONE

[HUG#1486221]

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 07.02.2011 - 17:15 Uhr
Sprache: Deutsch
News-ID 51158
Anzahl Zeichen: 2017

contact information:
Town:

Turku

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 159 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Organizational meeting of the Board of Directors of Biotie Therapies Corp."
steht unter der journalistisch-redaktionellen Verantwortung von

Biotie Therapies Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Biotie Announces Start of Clinical Study With Nepicastat (SYN117) in Cocaine Dep ...

TURKU, FINLAND -- (Marketwired) -- 05/10/13 -- BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 10 May 2013 at 9.00 a.m.Biotie Therapies today announced the start of a Phase 2 clinical study evaluating nepicastat (SYN117) in cocaine dependence. The Nat ...

Biotie: Selincro Launched in the United Kingdom ...

TURKU, FINLAND -- (Marketwired) -- 05/06/13 -- Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, B ...

Biotie: Selincro Launched in First European Markets ...

TURKU, FINLAND -- (Marketwired) -- 04/22/13 -- BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 22 April 2013 at 9:00 a.m.Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has started launching Selincro™ in the first European markets, ...

Alle Meldungen von Biotie Therapies Oyj